1-991:
Other diagnostic measures: Molecular monitoring of residual tumor (MRD)
- 1-991.0 Molecular genetic identification and preparation of patient-specific markers to identify residual tumor (minimal residual disease (MRD))
- 1-991.1 Patient-specific molecular genetic quantification of residual tumor (MRD monitoring)
- 1-991.2 Molekulargenetische Identifikation von krankheitsspezifischen Markern für die Bestimmung der Resttumorlast (Minimal Residual Disease [MRD])
- 1-991.3 Krankheitsspezifische molekulargenetische Quantifizierung der Resttumorlast [MRD-Monitoring]
Source
Provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).